Hypothesis

3 Matching Annotations

May 2026
54.241.53.176 54.241.53.176

2026.05.07.723402v1.full-html.html

1
1. scibot 15 May 2026
  
  in Public
  
  RRID:AB_2650863
  
  DOI: 10.64898/2026.05.07.723402
  
  Resource: (BioLegend Cat# 372106 (also 372105), RRID:AB_2650863)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2650863
  
  What is this?
  
  RRID:AB_2650863
Visit annotations in context

Tags

RRID:AB_2650863

Annotators

scibot

URL

54.241.53.176/7495727594302b82f508ab668fdf88fec4f573b5/2026.05.07.723402v1.full-html.html
Jun 2025
www.sciencedirect.com www.sciencedirect.com

Pre-clinical characterization of novel multi-client inhibitors of Sec61 with broad anti-tumor activity

1
1. scibot 18 Jun 2025
  
  in Public
  
  RRID:AB_2650863
  
  DOI: 10.1016/j.jpet.2025.103634
  
  Resource: (BioLegend Cat# 372106 (also 372105), RRID:AB_2650863)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2650863
  
  What is this?
  
  RRID:AB_2650863
Visit annotations in context

Tags

RRID:AB_2650863

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0022356525398472
May 2024
www.sciencedirect.com www.sciencedirect.com

Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity

1
1. scibot 09 May 2024
  
  in Public
  
  RRID:AB_2650863
  
  DOI: 10.1016/j.stem.2024.04.012
  
  Resource: (BioLegend Cat# 372106 (also 372105), RRID:AB_2650863)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2650863
  
  What is this?
  
  RRID:AB_2650863
Visit annotations in context

Tags

RRID:AB_2650863

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1934590924001395